Adaptive mutation in nuclear export protein allows stable transgene expression in a chimaeric influenza A virus vector

Journal of General Virology

Volumn 95, Issue PART 2, 2014, Pages 337-349

  Kuznetsova, Irina ^a   Shurygina, Anna Polina ^b   Wolf, Brigitte ^a   Wolschek, Markus ^a,c   Enzmann, Florian ^a   Sansyzbay, Abylay ^d   Khairullin, Berik ^d   Sandybayev, Nurlan ^d   Stukova, Marina ^b   Kiselev, Oleg ^b   Egorov, Andrej ^b   Bergmann, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c Avir Green Hills Biotechnology AG   (Austria)

^d The Research Institute for Biological Safety Problems   (Kazakhstan)

Author keywords

[No Author keywords available]

Indexed keywords

AG85A PROTEIN; EARLY SECRETORY ANTIGENIC TARGET 6; GREEN FLUORESCENT PROTEIN; HEMAGGLUTININ; INTERFERON; NONSTRUCTURAL PROTEIN 1; NUCLEAR PROTEIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC STABILITY; GENOME; IN VIVO STUDY; INFLUENZA; INFLUENZA VIRUS; LUNG; MELANOMA CELL; MOUSE; MUTATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SELF CONCEPT; SEQUENCE ANALYSIS; STABLE EXPRESSION; TRANSGENE; VIRUS REPLICATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL LINE; GENE EXPRESSION; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; INFLUENZA A VIRUS; MICE; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; VIRAL LOAD; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84892585039     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.056036-0     Document Type: Article

References (38)

1. Alonso-Caplen, F. V., Nemeroff, M. E., Qiu, Y. & Krug, R. M. (1992). Nucleocytoplasmic transport: the influenza virus NS1 protein regulates the transport of spliced NS2 mRNA and its precursor NS1 mRNA. Genes Dev 6, 255-267.
2. Bullido, R., Gómez-Puertas, P., Saiz, M. J. & Portela, A. (2001). Influenza A virus NEP (NS2 protein) downregulates RNA synthesis of model template RNAs. J Virol 75, 4912-4917.
3. Egorov, A., Brandt, S., Sereinig, S., Romanova, J., Ferko, B., Katinger, D., Grassauer, A., Alexandrova, G., Katinger, H. & Muster, T. (1998). Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J Virol 72, 6437-6441.
4. Ferko, B., Stasakova, J., Sereinig, S., Romanova, J., Katinger, D., Niebler, B., Katinger, H. & Egorov, A. (2001). Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice. J Virol 75, 8899-8908.
5. García-Sastre, A. (2000). Transfectant influenza viruses as antigen delivery vectors. Adv Virus Res 55, 579-597.
6. García-Sastre, A. & Palese, P. (1995). Influenza virus vectors. Biologicals 23, 171-178.
7. García-Sastre, A., Egorov, A., Matassov, D., Brandt, S., Levy, D. E., Durbin, J. E., Palese, P. & Muster, T. (1998). Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252, 324-330.
8. He, Q., Martinez-Sobrido, L., Eko, F. O., Palese, P., Garcia-Sastre, A., Lyn, D., Okenu, D., Bandea, C., Ananaba, G. A. & other authors (2007). Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines. Immunology 122, 28-37.
9. Heaton, N. S., Leyva-Grado, V. H., Tan, G. S., Eggink, D., Hai, R. & Palese, P. (2013). In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies. J Virol 87, 8272-8281.
10. Hoffmann, E. & Webster, R. G. (2000). Unidirectional RNA polymerase I-polymerase II transcription system for the generation of influenza A virus from eight plasmids. J Gen Virol 81, 2843-2847.
11. Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G. & Webster, R. G. (2000). A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97, 6108-6113.
12. Hoffmann, E., Stech, J., Guan, Y., Webster, R. G. & Perez, D. R. (2001). Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146, 2275-2289.
13. Kittel, C., Sereinig, S., Ferko, B., Stasakova, J., Romanova, J., Wolkerstorfer, A., Katinger, H. & Egorov, A. (2004). Rescue of influenza virus expressing GFP from the NS1 reading frame. Virology 324, 67-73.
14. Kittel, C., Ferko, B., Kurz, M., Voglauer, R., Sereinig, S., Romanova, J., Stiegler, G., Katinger, H. & Egorov, A. (2005). Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment. J Virol 79, 10672-10677.
15. Langley, W. A., Bradley, K. C., Li, Z. N., Smith, M. E., Schnell, M. J. & Steinhauer, D. A. (2010). Induction of neutralizing antibody responses to anthrax protective antigen by using influenza virus vectors: implications for disparate immune system priming pathways. J Virol 84, 8300-8307.
16. Manicassamy, B., Manicassamy, S., Belicha-Villanueva, A., Pisanelli, G., Pulendran, B. & García-Sastre, A. (2010). Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci U S A 107, 11531-11536.
17. Mänz, B., Brunotte, L., Reuther, P. & Schwemmle, M. (2012). Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells. Nat Commun 3, 802.
18. Muster, T., Rajtarova, J., Sachet, M., Unger, H., Fleischhacker, R., Romirer, I., Grassauer, A., Url, A., García-Sastre, A. & other authors (2004). Interferon resistance promotes oncolysis by influenza virus NS1-deletion mutants. Int J Cancer 110, 15-21.
19. Neumann, G. & Kawaoka, Y. (2002). Generation of influenza A virus from cloned cDNAs-historical perspective and outlook for the new millenium. Rev Med Virol 12, 13-30.
20. Neumann, G., Whitt, M. A. & Kawaoka, Y. (2002). A decade after the generation of a negative-sense RNA virus from cloned cDNA-what have we learned? J Gen Virol 83, 2635-2662.
21. O'Neill, R. E., Talon, J. & Palese, P. (1998). The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J 17, 288-296.
22. Ozawa, M., Victor, S. T., Taft, A. S., Yamada, S., Li, C., Hatta, M., Das, S. C., Takashita, E., Kakugawa, S. & other authors (2011). Replication-incompetent influenza A viruses that stably express a foreign gene. J Gen Virol 92, 2879-2888.
23. Palese, P., Muster, T., Zheng, H., O'Neill, R. & Garcia-Sastre, A. (1999). Learning from our foes: a novel vaccine concept for influenza virus. Arch Virol Suppl 15, 131-138.
24. Paterson, D. & Fodor, E. (2012). Emerging roles for the influenza A virus nuclear export protein (NEP). PLoS Pathog 8, e1003019.
25. Pena, L., Vincent, A. L., Ye, J., Ciacci-Zanella, J. R., Angel, M., Lorusso, A., Gauger, P. C., Janke, B. H., Loving, C. L. & Perez, D. R. (2011). Modifications in the polymerase genes of a swine-like triplereassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses. J Virol 85, 456-469.
26. Pena, L., Sutton, T., Chockalingam, A., Kumar, S., Angel, M., Shao, H., Chen, H., Li, W. & Perez, D. R. (2013). Influenza viruses with rearranged genomes as live-attenuated vaccines. J Virol 87, 5118-5127.
27. Percy, N., Barclay, W. S., García-Sastre, A. & Palese, P. (1994). Expression of a foreign protein by influenza A virus. J Virol 68, 4486-4492.
28. Read, E. K. & Digard, P. (2010). Individual influenza A virus mRNAs show differential dependence on cellular NXF1/TAP for their nuclear export. J Gen Virol 91, 1290-1301.
29. Rimmelzwaan, G. F., Verburgh, R. J., Nieuwkoop, N. J., Bestebroer, T. M., Fouchier, R. A. & Osterhaus, A. D. (2011). Use of GFPexpressing influenza viruses for the detection of influenza virus A/ H5N1 neutralizing antibodies. Vaccine 29, 3424-3430.
30. Robb, N. C., Jackson, D., Vreede, F. T. & Fodor, E. (2010). Splicing of influenza A virus NS1 mRNA is independent of the viral NS1 protein. J Gen Virol 91, 2331-2340.
31. + Th1 immune response and protect animals against tuberculosis challenge. Clin Vaccine Immunol 13, 898-904.
32. Skeiky, Y. A. & Sadoff, J. C. (2006). Advances in tuberculosis vaccine strategies. Nat Rev Microbiol 4, 469-476.
33. Song, H., Nieto, G. R. & Perez, D. R. (2007). A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. J Virol 81, 9238-9248.
34. Sutejo, R., Yeo, D. S., Myaing, M. Z., Hui, C., Xia, J., Ko, D., Cheung, P. C., Tan, B. H. & Sugrue, R. J. (2012). Activation of type I and III interferon signalling pathways occurs in lung epithelial cells infected with low pathogenic avian influenza viruses. PLoS ONE 7, e33732.
35. Talon, J., Salvatore, M., O'Neill, R. E., Nakaya, Y., Zheng, H., Muster, T., García-Sastre, A. & Palese, P. (2000). Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc Natl Acad Sci U S A 97, 4309-4314.
36. Wacheck, V., Egorov, A., Groiss, F., Pfeiffer, A., Fuereder, T., Hoeflmayer, D., Kundi, M., Popow-Kraupp, T., Redlberger-Fritz, M. & other authors (2010). A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1. J Infect Dis 201, 354-362.
37. Wang, L., Suarez, D. L., Pantin-Jackwood, M., Mibayashi, M., García-Sastre, A., Saif, Y. M. & Lee, C. W. (2008). Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry. Vaccine 26, 3580-3586.
38. Wolschek, M., Samm, E., Seper, H., Sturlan, S., Kuznetsova, I., Schwager, C., Khassidov, A., Kittel, C., Muster, T. & other authors (2011). Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency. J Virol 85, 2469-2473.